Center for Environmentally
Beneficial Catalysis

  • Home
  • Partnership with Archer Daniels Midland Advancing Biorefining Research at KU

Partnership with Archer Daniels Midland Advancing Biorefining Research at KU

Wednesday, April 27, 2011

In 2009, Archer Daniels Midland Company launched a three-year research program at CEBC to make industrial chemicals and fuels from agricultural-based renewable resources instead of petroleum.

Today, a portfolio of proprietary projects is well underway.

“We are very excited about the progress being made at CEBC,” said the ADM project manager, Dr. Padmesh Venkitasubramaniam.  “Two projects are being fast-tracked for further development.” 

CEBC has hired nine research associates and two graduate students to work on the research projects.  In addition, Dr. Gus Dassori, a process modeling engineer from ADM, has been involved with these projects to speed commercialization. 

“The progress has been outstanding, benefitting from active collaboration between the CEBC researchers and the ADM representatives,” said Darryl Fahey, CEBC Industrial Liaison. "This is a unique learning opportunity for our postdocs, and an ideal model for other collaborations."

With matching funds from the Kansas Bioscience Authority, the total investment for this partnership is $2.4 million.



CEBC Calendar

November 7, Tuesday - CEBC Industry Colloquium
Brandon Emme, Cellulose Team Leader, ICM, Inc.
"From Moonshining to Molecules: How ICM is moving farms to biotech"
9:00 a.m. - 10:00 a.m., 1501 Wakarusa Drive, Building B seminar room
10:00 a.m. discussion with students

November 8, Wednesday - Mandatory Lab Safety Meeting
All researchers at 1501 Wakarusa Dr. must attend

9:00 a.m. in Building B seminar room

December 5, Tuesday - CEBC Industry Colloquium
Dr. John Warner, President & Chief Technology Officer, Warner Babcock Institute for Green Chemistry
"Title TBA"

11:00 a.m. - 12:00 p.m., Spahr Auditorium, 2 Eaton Hall, 1520 W. 15th Street

KU Today
48 nationally ranked graduate programs.
—U.S. News & World Report
Pharmacy school No. 2 nationally for NIH funding